With respect to ER-negative, hormone-independent breast cancer cell lines, SERMs have been demonstrated to exert some antiproliferative activity in vitro49,50 by mechanisms which have not been elucidated, although other findings have been published.51 This evidence concerns the gene ESR1 and breast carcinoma.